ATP1B3
1 paper1 finding
- In silico1
Interventions
1Bisacodyl
downin silico1
1 study
Bisacodyl
downin silico1
Bisacodyl inhibits ATP1B3 in silico.
“cardiac glycosides, Bisacodyl, Olsalazine, and Tegoprazan might be potential therapeutics for aging by inhibiting ATP1B3.”
In silico
Health science reports29 Mar 2026
Latest
1 in 12 monthsHealth Science Reports
Systematic Druggable Genome-Wide Analysis Identifies Therapeutic Targets for Aging: A Mendelian Randomization Study
Computational studyMechanisms